Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLeukemiaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLeukemiaTeam Member asked a question 💭
Hazelhurst, WI
March 10, 2024
 · 
Reactions
A MyLeukemiaTeam Member

Anyone try the medication Ivosidenib (Tibsovo)? My dr has me on it. It targets the mutation IDH1.

October 26, 2024
MyLeukemiaTeam

Chronic myelomonocytic leukemia (CMML) is a rare type of blood cancer. About 1,100 people are diagnosed with CMML each year in the United States. It is more common in older adults, with about 90 percent of those diagnosed being at least 60 years old. Men are twice as likely to get CMML as women. If you are living with CMML Show Full Answer

Chronic myelomonocytic leukemia (CMML) is a rare type of blood cancer. About 1,100 people are diagnosed with CMML each year in the United States. It is more common in older adults, with about 90 percent of those diagnosed being at least 60 years old. Men are twice as likely to get CMML as women. If you are living with CMML, you can share your experiences and connect with others on MyLeukemiaTeam, a social network for people with leukemia and their loved ones.

September 6, 2024
A MyLeukemiaTeam Member

Hi Mary I was diagnosed with CMML-1 about 9 months ago. Been through seven rounds of chemotherapy thus far.

March 10, 2024

Related Questions

View All
A MyLeukemiaTeam Member asked a question 💭
San Antonio, TX